Monogram Biosciences, Inc. (MGRM) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 57 transactions totaling $3.5M, demonstrating a bullish sentiment with $2.5M in net insider flow. The most recent transaction on Oct 7, 2025 involved a transaction of 296,385 shares valued at $0.
No significant insider buying has been recorded for MGRM in the recent period.
No significant insider selling has been recorded for MGRM in the recent period.
Based on recent SEC filings, insider sentiment for MGRM is bullish with an Insider Alignment Score of 86/100 and a net flow of $2.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Monogram Biosciences, Inc. (MGRM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading MGRM stock, having executed 57 transactions in the past 90 days. The most active insider is Kenneth F. Siebel (Executive), who has made 34 transactions totaling $17.2M.
Get notified when executives and directors at MGRM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Knape Noel | Executive | Disposition | 296,385 | $N/A | $0 | |
| Oct 7, 2025 | Sexson Benjamin | Executive | Disposition | 4,006,330 | $N/A | $0 | |
| Oct 7, 2025 | Shamaei Kamran | Executive | Disposition | 2,926 | $N/A | $0 | |
| Oct 7, 2025 | Unis Douglas | Executive | Disposition | 3,532,622 | $N/A | $0 | |
| Aug 5, 2009 | F. Siebel Kenneth | Executive | Tender | 1,635,333 | $4.55 | $7.4M | Large |
| Aug 5, 2009 | F. Siebel Kenneth | Executive | Tender | 1,425,138 | $4.55 | $6.5M | Large |
| Feb 17, 2009 | F. Siebel Kenneth | Executive | Other | 16,666 | $3.50 | $58.3K | |
| Feb 17, 2009 | F. Siebel Kenneth | Executive | Sale | 5,466 | $3.53 | $19.3K | |
| Feb 9, 2009 | F. Siebel Kenneth | Executive | Sale | 1,200 | $4.24 | $5.1K | |
| Feb 2, 2009 | F. Siebel Kenneth | Executive | Sale | 3,334 | $2.99 | $10.0K | |
| Dec 31, 2008 | F. Siebel Kenneth | Executive | Purchase | 10,000 | $2.21 | $22.1K | |
| Dec 31, 2008 | F. Siebel Kenneth | Executive | Purchase | 22,000 | $2.21 | $48.6K | |
| Dec 31, 2008 | F. Siebel Kenneth | Executive | Sale | 1,666 | $2.20 | $3.7K | |
| Dec 30, 2008 | F. Siebel Kenneth | Executive | Purchase | 25,000 | $2.20 | $55.0K | |
| Dec 29, 2008 | F. Siebel Kenneth | Executive | Purchase | 50,000 | $2.15 | $107.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 2 | $13.9M | 79.7% |
Purchase(P) | 40 | $3.0M | 17.1% |
Sale(S) | 8 | $491.7K | 2.8% |
Other(J) | 1 | $58.3K | 0.3% |
Exercise(M) | 2 | $6.7K | 0.0% |
Disposition(D) | 4 | $0 | 0.0% |
Insiders at Monogram Biosciences, Inc. are accumulating shares at an accelerated pace. With 9 insiders making 57 transactions totaling $3.0M in purchases versus $491.7K in sales, the net buying activity of $2.5M signals strong executive confidence. Kenneth F. Siebel (Executive) leads the buying activity with $17.2M in transactions across all time.